Retreat
- Saw PalmettoCategory D
LiverTox Category D. Rare cases of acute hepatitis reported; causality uncertain. Some reports confounded by concurrent pharmaceuticals.
LiverTox →
Supplement Facts
5 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| D-Aspartic Acid, Powder D-Aspartic Acidamino_acidUNII · 4SR0Q8YD1X | 1500 mg | — |
| Fenugreek herbUNII · 654825W09Z | 350 mg | — |
| Saw Palmetto herbUNII · J7WWH9M8QS LiverTox D | 160 mg | — |
| Androst-3, 5-dien-7, 17-dione Arimistaneherb | 75 mg | — |
| Diindolylmethane herbUNII · SSZ9HQT61Z | 50 mg | — |
5 flagged · authority citations
- ◐ CAUTIONFD&C Blue #1color
EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.
- ◐ CAUTIONFD&C Green #3color
Banned in EU countries (not listed in Reg 1333/2008 Annex II). Permitted in US under 21 CFR 74.203. Used in some capsule coatings.
- ◐ CAUTIONFD&C Red #3color
FDA revoked food/ingested-drug color additive approval for FD&C Red 3 in January 2025 (Docket FDA-2022-C-2886). Manufacturers have until January 2027 (foods) / January 2028 (ingested drugs) to reformulate.
- ◐ CAUTIONFD&C Red #40color
EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).
- ◐ CAUTIONFD&C Yellow #6color
EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Gelatin · Magnesium Stearate · Silicon Dioxide